Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PHT Corporation
Boston, MA, USA
- Ownership
- Private
- Development stage
- Other
01
Overview
PHT Corporation was the market leader in electronic patient reported outcome (ePRO) solutions, supporting over 400 global clinical trials with more than 100 biopharmaceutical clients. Its platforms enabled high-quality, time-stamped assessments from patients worldwide and were successfully used in at least 12 NDA submissions and seven approvals. The company was acquired by ERT in 2015 to strengthen ERT’s leadership position in eClinical Outcome Assessments. ERT itself later rebranded as Clario.
- Therapeutic areas
- Other
- Modalities
- Non-pharmacological therapy
- Industry
- Contract Research Organization
02
Partnerships
CMIC Group (Japan’s first CRO)Numerous partnerships with top pharmaceutical companies as customers/users
Beyond the preview
Go deeper on PHT Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PHT Corporation.